There is a growing need to augment traditional human-measured lengths such as RECIST for treatment response assessment in oncology.
Brainomix’s Cancer solution has been trained to characterize and quantify solid-tumors using thousands of cases from leading academic institutions, unlocking objective measurement of tumor lengths, and other biomarkers such as tumor volume.